Synthorx Raises $10M to Expand Use of Synthetic DNA in Biologics
Xconomy
JULY 19, 2016
Existing investors Avalon Ventures and Correlation Ventures joined in the round. The company’s technology is based on research led by Floyd Romesberg, a biological chemist at The Scripps Research Institute. The San Diego firms have invested $6 million since 2014, when Synthorx was founded , CEO Court Turner said yesterday.
Let's personalize your content